BGT · ASX

Bio-Gene Technology Ltd. (ASX:BGT)

AU$0.034

 0.004 (13.333%)
ASX:Live
17/03/2025 11:27:03 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BGT Overview

BGT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About BGT

Website

Bio-Gene Technology Ltd.

Telephone

N/A

Address

Description

Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.

BGT Price Chart

Key Stats

Market Cap

AU$6.04M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.03 - 0.09

Trade Value (12mth)

AU$2,682.00

1 week

0%

1 month

-18.92%

YTD

-26.83%

1 year

-56.52%

All time high

0.35

Key Fundamentals

EPS 3 yr Growth

-25.70%

EBITDA Margin

%

Operating Cashflow

-$3m

Free Cash Flow Return

-91.60%

ROIC

-80.10%

Interest Coverage

N/A

Quick Ratio

8.50

Other Data

Shares on Issue (Fully Dilluted)

201m

HALO Sector

Industrials

Next Company Report Date

21-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BGT Announcements

Latest Announcements

Date Announcements

17 March 25

Gene Technology Ltd. - BGT to present at virtual healthcare

×

Gene Technology Ltd. - BGT to present at virtual healthcare

27 February 25

Gene Technology Ltd. - Appendix 4D and Half-Year Accounts 31 December 2024

×

Gene Technology Ltd. - Appendix 4D and Half-Year Accounts 31 December 2024

04 February 25

Gene Technology Ltd. - BGT Investor Webinar 4-Feb-25 Slides

×

Gene Technology Ltd. - BGT Investor Webinar 4-Feb-25 Slides

31 January 25

Gene Technology Ltd. - Investor Webinar Tue 4 Feb 2025

×

Gene Technology Ltd. - Investor Webinar Tue 4 Feb 2025

30 January 25

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

×

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

29 January 25

Gene Technology Ltd. - BGT Awarded U.S. Department of Defense Grants

×

Gene Technology Ltd. - BGT Awarded U.S. Department of Defense Grants

02 December 24

Gene Technology Ltd. - Notification of cessation of securities - BGT

×

Gene Technology Ltd. - Notification of cessation of securities - BGT

29 November 24

Gene Technology Ltd. - Chair's Address to Shareholders

×

Gene Technology Ltd. - Chair's Address to Shareholders

29 November 24

Gene Technology Ltd. - CEO's Presentation

×

Gene Technology Ltd. - CEO's Presentation

29 November 24

Gene Technology Ltd. - CEO's Address to Shareholders

×

Gene Technology Ltd. - CEO's Address to Shareholders

29 November 24

Gene Technology Ltd. - Results of Meeting

×

Gene Technology Ltd. - Results of Meeting

31 October 24

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

×

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

29 October 24

Gene Technology Ltd. - Notice of Annual General Meeting/Proxy Form

×

Gene Technology Ltd. - Notice of Annual General Meeting/Proxy Form

25 October 24

Gene Technology Ltd. - Bio-Gene Receives $535000 R&D Tax Incentive

×

Gene Technology Ltd. - Bio-Gene Receives $535000 R&D Tax Incentive

04 October 24

Gene Technology Ltd. - Date of 2024 Annual General Meeting

×

Gene Technology Ltd. - Date of 2024 Annual General Meeting

02 October 24

Gene Technology Ltd. - BGT Investor Presentation Oct24

×

Gene Technology Ltd. - BGT Investor Presentation Oct24

06 September 24

Gene Technology Ltd. - Investor Webinar Presentation 06 Sep 24

×

Gene Technology Ltd. - Investor Webinar Presentation 06 Sep 24

02 September 24

Gene Technology Ltd. - Investor Webinar - Shareholder update 06 SEP 24

×

Gene Technology Ltd. - Investor Webinar - Shareholder update 06 SEP 24

28 August 24

Gene Technology Ltd. - Appendix 4E and 2024 Annual Report

×

Gene Technology Ltd. - Appendix 4E and 2024 Annual Report

28 August 24

Gene Technology Ltd. - Appendix 4G and 2024 Corporate Governance Statement

×

Gene Technology Ltd. - Appendix 4G and 2024 Corporate Governance Statement

14 August 24

Gene Technology Ltd. - Envu collaboration on Flavocide for mosquito management

×

Gene Technology Ltd. - Envu collaboration on Flavocide for mosquito management

08 August 24

Gene Technology Ltd. - APVMA Pre Application Assistance

×

Gene Technology Ltd. - APVMA Pre Application Assistance

30 July 24

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

×

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

17 May 24

Gene Technology Ltd. - Company Secretary Appointment/Resignation

×

Gene Technology Ltd. - Company Secretary Appointment/Resignation

BGT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.6 3.2 29.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.6 -26.6 30.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -10.0 -25.0 -30.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.04 0.02 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 30.7 -49.9 -23.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 153 168 186 Lock Lock Lock
Basic m Lock Lock Lock Lock 153 168 186 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 611.9 -66.5 -87.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 3 3 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 261.5 -191.9 -107.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 40.1 -109.9 -1,855.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 60 210 1,955 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -3 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -15.2 -6.5 14.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -754.7 -2,400.7 -16,716.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.6 -6.5 14.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -764.5 -2,431.0 -16,926.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -4 -3 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.6 -6.2 22.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -653.8 -2,074.5 -13,150.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 4 0 2 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.4 -63.8 15.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4.5 -22.0 -150.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 3 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 7 4 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -6 -3 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Equity $m Lock Lock Lock Lock 6 3 3 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 6 3 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 47.6 -48.6 -13.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -39.9 -80.7 -76.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -46.5 -96.1 -86.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -64.8 -76.5 -103.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -55.4 -65.2 -80.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -37.9 -69.0 -91.6 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.9 0.8 0.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -101.2 -92.8 -79.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.9 6.2 8.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.9 6.2 8.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 90.6 83.5 75.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -197.5 -570.9 -796.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.9 0.3 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 49.1 79.5 257.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -751.2 -2,373.2 -16,448.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -45.8 -92.3 -95.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -39.9 -80.7 -76.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -46.5 -96.1 -86.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -46.5 -96.1 -86.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 393.9 1,080.7 9,658.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 393.9 1,080.7 9,658.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 209.8 196.7 84.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 184.0 884.0 9,573.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BGT Shortsell

Frequently Asked Questions

The current share price of Bio-Gene Technology Ltd. (BGT:ASX) is AU$0.034.
The 52-week high share price for Bio-Gene Technology Ltd. (BGT:ASX) is AU$0.09.
The 52-week low share price for Bio-Gene Technology Ltd. (BGT:ASX)? is AU$0.03.
Bio-Gene Technology Ltd. (BGT:ASX) does not pay a dividend.
Bio-Gene Technology Ltd. (BGT:ASX) does not pay a dividend.
Bio-Gene Technology Ltd. (BGT:ASX) does not offer franking credits.
Bio-Gene Technology Ltd. (BGT:ASX) is classified in the Industrials.
The current P/E ratio for Bio-Gene Technology Ltd. (BGT:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.